v3.26.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Millions
Jun. 30, 2026
Dec. 31, 2025
Current Assets    
Cash and cash equivalents $ 1,740 $ 715
Restricted cash and cash equivalents 42 42
Accounts and notes receivable – net 1,751 1,669
Inventories 1,210 1,172
Prepaid and other current assets 113 121
Assets of discontinued operations 0 1,856
Total current assets 4,856 5,575
Property, plant and equipment – net of accumulated depreciation (June 30, 2026 - $3,694; December 31, 2025 - $3,565) 3,379 3,464
Other Assets    
Goodwill 7,840 7,915
Other intangible assets 2,789 2,936
Investments and noncurrent receivables 981 432
Deferred income tax assets 221 282
Deferred charges and other assets 995 971
Total other assets 12,826 12,536
Total Assets 21,061 21,575
Current Liabilities    
Short-term borrowings 0 60
Accounts payable 978 995
Income taxes payable 53 54
Accrued and other current liabilities 970 882
Liabilities of discontinued operations 0 314
Total current liabilities 2,001 2,305
Long-Term Debt 3,125 3,134
Other Noncurrent Liabilities    
Deferred income tax liabilities 295 405
Pension and other post-employment benefits – noncurrent 400 432
Other noncurrent obligations 1,359 1,196
Total other noncurrent liabilities 2,054 2,033
Total Liabilities 7,180 7,472
Commitments and contingent liabilities
Stockholders' Equity    
Common stock (authorized 555,555,556 shares of $0.01 par value each; issued 2026: 135,038,855 shares; 2025: 136,398,482 shares) 1 1
Additional paid-in capital 38,710 38,721
Accumulated deficit (24,326) (24,278)
Accumulated other comprehensive loss (616) (525)
Total DuPont stockholders' equity 13,769 13,919
Noncontrolling interests 112 184
Total equity 13,881 14,103
Total Liabilities and Equity $ 21,061 $ 21,575